Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 18.0B | 18.6B | 17.1B | 18.1B |
Cost of revenue | 15.6B | 17.9B | 15.0B | 16.0B |
Gross profit | 2.3B | 690M | 2.1B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | -15M |
Other operating expenses | -49M | -6M | -23M | -18M |
Operating income | 2.4B | 696M | 2.1B | 2.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 268M | 264M | 256M | 261M |
Other income expense | -68M | 87M | 34M | 46M |
Pretax income | 2.0B | 519M | 1.9B | 1.9B |
Tax provision | 324M | -8M | 295M | 307M |
Net income | 1.7B | 527M | 1.6B | 1.6B |
Basic EPS | 7.3 | 2.2 | 6.8 | 6.9 |
Diluted EPS | 7.3 | 2.2 | 6.8 | 6.9 |
Basic average shares | 234.4M | 236M | 237.5M | 238.9M |
Diluted average shares | 235.3M | 237M | 238.6M | 239.6M |
EBITDA | 2.7B | 1.2B | 2.6B | 2.6B |
Net income from continuing op. | 1.7B | 527M | 1.6B | 1.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |